Janssen Diagnostics to Present at the Biomarker World Congress on Next Generation Sequencing of Circulating Tumor Cells from the CELLSEARCH® System

Raritan, New Jersey, April 28, 2015 (Newswire.com) - Janssen Diagnostics, a precision diagnostics company committed to providing technologies that help improve patient outcomes, announced that Dr. Charles Saginario, Principal Scientist at Janssen Diagnostics, is scheduled to present at the Biomarker World Congress 2015.  The event is taking place at the Loews Philadelphia Hotel in Philadelphia, PA.

The presentation is entitled, "Next Generation Sequencing of Circulating Tumor Cells from the CELLSEARCH® System."

The Details of the presentation are as follows:

    Date:  Tuesday, May 5th

    Track:  Cell-Free Biomarkers and Diagnostics

    Time: 4:35 PM Eastern

About Janssen Diagnostics

At Janssen Diagnostics we are passionate about the promise of personalized medicine and its potential to improve outcomes for specific patients through targeted therapies.

We aspire to help doctors and researchers better identify, prevent or intervene earlier with diseases, or cure people with the right medicines for the right person, at the right time.

Being part of Janssen puts us in a strong position, enabling us to bridge Janssen’s extensive pharmaceutical knowledge-base and global capabilities, with our own heritage and talent in research technology, diagnostics and health information technology to deliver integrated solutions into the hands of healthcare providers.

What makes Janssen Diagnostics unique is the concentration of minds, personnel and skills at the heart of Pharma R&D, specifically organized to develop and commercialize products and services around meeting patient needs of both today and tomorrow.

To speak with Dr. Saginario or learn more about Janssen Diagnostics, please contact:

Frederik Wittock
Janssen Global Services, LLC
[email protected] or +32 14 60 57 24

Scott Canady
[email protected] or 809-481-3790